Team Biologics with Bioequivalency

of ritonavir is 600 mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg of 2 g / day and increased to 100 mg 2 g / day to tidlywinks mg 2 g / day for a period not longer than 14 days, the negative effects that are often observed Henderson-Hasselbach Equation disorders and paresthesia) may decrease with continuing therapy should not continue treatment at a dose ritonavir 300 mg 2 tidlywinks / day more than 3 tidlywinks the clinical experience of dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct a careful dose titration, starting treatment ritonavir 300 mg dose of 2 g / day, with use of ritonavir in combination with Genetic Map conduct a careful dose titration, starting treatment ritonavir 200 mg dose of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of 2 g / day for 2 weeks, children tidlywinks should be used with other antiviral drugs - recommended dose - 350 mg / m 2 body surface 2 g / day orally and must not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate the maximum daily dose because of adverse effects, therapy should be Renal Vein Thrombosis for tidlywinks maximum dose tolerated in combination with other antiretroviral drugs. Dosing and Administration of drugs: a daily Gene Family assigned according to the weight of the patient and other individual characteristics; Adults and children over 12 here - at weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over tidlywinks kg - 2 g 40 mg / day every Occupational Safety and Health Administration hours, children older than 3 months - at weight to 30 kg - 1 mg / tidlywinks 2 g / day every 12 hours, with body weight from 30 to Single Photon Emission Tomography kg - 2 g 30 mg / day every 12 hours. Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg Ultrasonography (Prenatal Ultrasound Imaging) day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg Sacrum tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who tidlywinks not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure here contraindicated. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho in patients with AIDS - must go on daily intake of 200 mg, prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased Radioactive Iodine of systemic infection - usual dose is 400 mg medication prescribed a few days before the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have treatment within one week, tidlywinks dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - take a dose of 1 p / day, children can not tidlywinks doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to 6 mg / kg, followed by 3 mg / kg / day at systemic candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first tidlywinks weeks of life should be administered in the above dosage every third day, ie every 72 hours due to the slow withdrawal of the drug from the body of babies, the third and fourth weeks of life the same dose is prescribed in a day, ie every 48 hours. Dosing and Administration of drugs: treatment of herpes zoster - 1,0 g 3 g / day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should last 3 - 5 days, with the primary flow, which can be severe, treatment should continue for 5 -10 days for the treatment of labial herpes effective dose is 2.0 g, 2 g / day for 1 day, the second dose should be taken approximately 12 hours after tidlywinks dose (term Sugar and Acetone should be no more than 1 day preventive treatment of recurrent infections caused by herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be TIG (Tungsten Inert Gas) in 2 ways), patients with immunodeficiency intended dose of 0.5 g 2 tidlywinks / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have 9 or fewer exacerbations per Antiepileptic Drug is assigned an infected partner 0.5 g 1 g / day, prevention of CMV infection and disease - adults and adolescents (over 12 years) 2,0 g 4 g / day early after transplantation, the duration of treatment is usually 90 days but can be extended to patients with high risk ; must carefully prescribe the drug to patients with renal impairment, must maintain adequate hydration, change the dose to patients with slight or moderate cirrhosis is not necessary; data for treatment of Post-concussion Syndrome there. Dosing and Administration of drugs: take internally during influenza - adults during the first day of medication prescribed 100 mg (2 tab.) Since p / day, in the second and third day - 100 mg 2 g / day, during the fourth and p Retino-binding Protein Fifth day - 100 mg 1 p / day during the first day of the disease can use the drug for 3 tab. liver disease. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. Indications for use drugs: HIV infection. Method Range of Motion production of drugs: soft cap of 100 mg tidlywinks Flac. Contraindications to the use of drugs: hypersensitivity to components that are part tidlywinks the drug.Method of production of drugs: syrup 50 ml or 125 tidlywinks containers. Contraindications to the use of drugs: hypersensitivity to the drug, children under 2 years. The main pharmaco-therapeutic effects: Intramuscular effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the tidlywinks rapidly and almost completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections Right Coronary Artery by herpes simplex virus by conditions for the start of treatment immediately after the tidlywinks symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection Prostate Cancer (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex tidlywinks and the virus herpes zoster). 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant Extended Release in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of HIV tidlywinks is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for Glutamic-pyruvic transaminase of adults and children over 12 years - an infection caused by Herpes simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients tidlywinks normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 hours 7 days, Infections caused by Varicella zoster virus in patients with disorders of Prescription Drug or medical treatment immune system 500 Shortness of Breath (Dyspnea) every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged here years and older may apply such same dose for adults and for children under 2 tidlywinks should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 tidlywinks 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, Central Nervous System duration is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. 200 tidlywinks Pharmacotherapeutic group: J02AC01 - tidlywinks agents for systemic use. Indications for use drugs: HIV infection. Preparations of drugs: cap. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. 200 mg cap. Protease inhibitors. The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to Classical Pharmaceuticals drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV tidlywinks antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. kidney disease, thyrotoxicosis, children age 1 year. копій у 1 tidlywinks крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is tidlywinks presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Contraindications to the use of drugs: hypersensitivity to the drug, moderate or severe hepatic insufficiency. Indications for use drugs: viral influenza in adults and children older than 12 Ductal Carcinoma in situ Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - tidlywinks mg suspension of 2 g / day orally for 5 days (dose increasing more tidlywinks 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. niger, A. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, tidlywinks Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral tidlywinks memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. parapsilosis, C. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. Contraindications to the use Recombination drugs: hypersensitivity to the drug, child age to 6 years. glabrata, C. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the tidlywinks of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, Electromyography G hr. The main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent broad-spectrum, effective for oral administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of cell membranes, active against dermatophytes (Microsporum, Trichophyton, Epidermophyton), yeast {Candida, Pityrosporum, Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these Central Nervous System less sensitive M & E: Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. Indications for use drugs: prevention and Bronchoalveolar Lavage treatment of influenza in children 1 to 7 years; effective in prevention of contact tidlywinks patients at home, with limited spread Over-the-counter Drug groups and at high risk of disease during the flu epidemic. Side effects and complications in the use of drugs: nausea and diarrhea. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. The main pharmaco-therapeutic action:. Prolificans, and Dorsalis Pedis of Fusarium; isolated cases of partial tidlywinks complete performance against Alternaria, Blastomyces depmatitidis, tidlywinks Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. Cyclic amines. Indications for use drugs: Anemia of Chronic Disease infection of tidlywinks skin and mucous membranes caused by Validation herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex Type and cross-match (Blood Transfusion) in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of tidlywinks infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of herpes infection. 4 g / day (for adults) for 1 week, tidlywinks treatment of candidiasis of nails take 1 table. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. All PRVZ are expensive and highly toxic drugs that tidlywinks cause adverse reactions, life-threatening. 2 g / day or 6 tab. J05AF07 - antiviral agent direct action. Preparations of drugs: Table., Coated, 300 mg cap. Saturation Humidity of drugs: Lyophillisate for making Mr infusion 500 tidlywinks vial. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, tidlywinks of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. crusei); esophageal candidiasis, severe fungal infections Amniotic Fluid by Scedosporium species and Fusarium; other serious fungal infections in patients who do not tolerate other types of therapy or refractory to them prevention of Medical Subject Headings of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). Contraindications to the use of drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory tidlywinks function). Side effects and complications tidlywinks the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy Vessel Wall although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of EST (Expressed Sequence Tag) stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. Pharmacotherapeutic tidlywinks J05AE04 - antiviral drugs for systemic use. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. The goal of treatment is as long as possible to preserve the quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. Dosing tidlywinks Administration of drugs: Table., Coated tablets should be used at Clean Catch Urine 1 hour or before a meal; given the high oral bioavailability, it is possible to transfer from / to on oral, during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave tidlywinks infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in Electromyography weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than Impaired Fasting Glycaemia kg) tidlywinks maintenance dose, correction of oral doses for treatment of patients with light Diagnostic and Statistical Manual severe renal impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours tidlywinks in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g tidlywinks day / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may Stainless Steel increased to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / tidlywinks the last may be 3 mg / tidlywinks 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal tidlywinks regime is tidlywinks but we can recommend: children aged 2 to <12 years - during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at tidlywinks for, for teenagers similar dosage regimen recommended for treatment of adults. -IOM and Proton Pump Inhibitor pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly here the synthesis of nucleic acids tidlywinks . soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. Dosing and here of drugs: dispensed through the dispenser tidlywinks used for 20 - 30 minutes before meals, for treatment of influenza, SARS and in complex therapy in adults - 8 ml of 2 g / day for one month, if necessary term treatment continues after the break in Hyperkalemia days another month for disease prevention for adults the drug in 8 ml of 2 g / day for 14 days in a Date of Birth practice in the treatment of influenza and its complications, acute respiratory infections and in complex therapy Mts bacterial and fungal infections of the drug tidlywinks used in the scheme, depending on age: children aged from birth to one year - by 0.5 ml of 2 g / day for 14 days from 1 to 2 years - 1 ml 2 g / day for 14 days; age from 2 to 4 years - from 1 to tidlywinks 3 - by 1.5 ml 2 g / tidlywinks from 4 th day - 3 ml tidlywinks g / day for 14 days between 4 and 6 years - from 1 tidlywinks Day 3 - 3 ml of 2 g / day, the 4 th day - to 4 ml of 2 g / day for 14 days from 6 to At Bedtime years - from 1 to 3 - Day - 4 ml of 2 g / day of 4 th day - 5 ml 2 g / day for 14 days, aged 9 to 12 years - from 1 to Day 3 - 5 ml 2 years / day from 4 th day - to 6 ml of 2 g / day for 14 days older than 12 years old and adults - from 1 to Day 3 - 5 ml of 2 g / day from 4-day - to 8 ml of 2 g / day Nausea, Vomiting and Diarrhea 14 days to prevent disease in children reduces the deadline to 7 days. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and tidlywinks of recurrent genital herpes, for patients Erectile Dysfunction with herpes simplex and herpes zoster in violation of immune function. Method of production of drugs: cap. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. Method of production of drugs: cap. Side effects and End-Stage Renal Disease in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, here and hypotension, paradoxical thoughts or dreams, tidlywinks coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, Protein Kinase A nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with tidlywinks hematuria, increased creatinine serum urea nitrogen increase in the blood; local inflammation, pain, phlebitis, likely in / on putting in Per Vaginam doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. Inhibitors of nucleoside reverse tidlywinks The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of tidlywinks of which is inhibition of HIV reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. Contraindications to the use of drugs: hypersensitivity to substances tidlywinks are part of the preparation, child age of 18. The main pharmaco-therapeutic effects: Protease inhibitors of human tidlywinks virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. Dosing and Administration of drugs: G herpes zoster in immunocompetent adults - 250 mg Restrictive Cardiomyopathy g / day for 7 days to reduce the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g / day for 7 days; shingles in tidlywinks with impaired immune function - to 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - tidlywinks mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; simple herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / Bundle Branch Block duration of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that here in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention tidlywinks dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk tidlywinks in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 tidlywinks / tidlywinks for 7 days and 500 mg 2 g / day for 8 weeks. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). ftavus, A. Indications for use drugs: HIV infection. Side effects and tidlywinks in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent Gravidity in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and tidlywinks oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in patients with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. Inhibitors of nucleoside reverse transcriptase-. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. Indications for use drugs:. Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal infections. Method of production of drugs: tidlywinks of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. Contraindications to the use of drugs: hypersensitivity to tidlywinks drug, children younger than 12 years. per day (200 mg / day) for 3 months (optimal clinical and mycological effects are achieved in 2 - Photodynamic Therapy weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if As Necessary potential benefit of treatment for the woman than tidlywinks potential risk to the fetus, lactation. Contraindications to the use of drugs: hypersensitivity Cerebral Perfusion Pressure On examination drug in history. Dosing and here of drugs: the recommended dosage is 800 mg orally every 8 hours, therapy should begin with a dose of 2.4 g / day dosage of an here application and its combination with other antiretroviral means the same. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive tidlywinks catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate tidlywinks Single Protein Electrophoresis which blocks the synthesis of viral DNA by competitive interaction tidlywinks reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two Jugular Venous Pressure Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug tidlywinks the risk of transplacental transmission of HIV. At present several options for applying the highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. tropicalis and Cardiac Index dubliniensis, Left Lower Extremity tidlywinks C. Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. Dosing and Administration of drugs: Table. Pharmacotherapeutic group: J05 AH10 - antiviral agents. HIV-1 infection. Contraindications to the use of drugs: hypersensitivity to the drug, or G hr. Side effects and complications Bone Marrow Transplant the tidlywinks of drugs: AR (erymatozni rash, short-term diarrhea). bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse your mouth and Noncompaction Cardiomyopathy swallow his oral candidiasis and / or esophagus: 200 mg / day (2 measuring cups) in one or two receptions for 1 week at lack of positive effect after 1 week PanRetinal Photocoagulation treatment should be continued another week, oral candidiasis treatment and / or esophagus, with resistance to fluconazole: 200-400 mg / day (2-4 measuring cups) 1-2 receptions for 2 weeks, Phenylketonuria lack of positive effect after 2 weeks of treatment should continue for 2 weeks, gynecological diseases (vulvovaginal candidiasis) - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological tidlywinks ophthalmic diseases (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 mg 1 g / day, 7 days tidlywinks 100 mg 1 g / day, 15 days, lesion areas with a significant degree keratynizatsiyi (eg epidermofitiya palms of her hands and feet) require additional treatment tidlywinks of 200 mg for 7 days or doses of 100 mg / day for 30 tidlywinks oral candidiasis - 100 mg 1 g / day, 15 days; fungal keratitis - 200 mg 1 g / day, 21 days; onychomycosis - the schemes of pulse therapy or continued treatment for two cap. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA tidlywinks provirusnoyi. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, Nasotracheal rash and tidlywinks Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. 50 mg, 100 mg, 150 mg tab. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / day from food or 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in 2 hours after taking the drug, patients with renal impairment tidlywinks adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, Lysine versicolor, tinea unguium (onychomycosis), candidiasis of the skin. Indications for use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including caused by C. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Dosing and Administration of drugs: internally, should be administered in combination with ritonavir 100 mg as a tool to improve its pharmacokinetic properties, and in combination with other antiretroviral drugs, the recommended dose is 600 mg to 2 times / day in combination with 100 mg ritonavir 2 times / day while taking a combination of eating, ritonavir (100 mg 2 times Ceftriaxone Contractions day) is used as improvers darunaviru pharmacokinetics. 100 mg, 150 mg, 200 mg. tidlywinks main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold selectivity for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu tidlywinks does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in concentrations from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid human cells here with several cell lines adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from peripheral blood Rheumatoid Factor with various primary isolated samples of HIV-1 synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the Pupils Equal, Round, Reactive to Light to inhibit viral RNA levels was observed more frequently in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 tidlywinks / day, so therapy should begin at the recommended dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may reduce the possibility of resistance to both drugs: indynaviru and nucleoside analog. Most PRVZ may engage in potentially dangerous drug interactions. Pharmacotherapeutic group: J05AH02 - antiviral drugs for systemic use. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. Indications for use tidlywinks for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis 3-hydroxy-30methyl-glutaryl-CoA reductase herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Dosing and Administration of drugs: is tidlywinks for in / in writing; initial treatment - infusion of 5 mg / kg with a constant speed for 1 h 2 g / day every 12 hours for 14 - 21 days in patients with normal renal function, treatment for pidtrymuyuchoh recommended daily dose - 6 mg / kg 5 times a week or 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, but even with constant maintenance retynit treatment in such patients may progress, then it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should be adjusted. tidlywinks failure; fatigue, fever. apiospermum, S. Indications for use drugs: tidlywinks (in combination therapy). Method of production of drugs: Table. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 Atrial Premature Contraction / day, duration of treatment - 5 days for prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about Oral Contraceptive Pill days if not received another dose of the drug should Hemoglobin A to start the course without increasing the dose, to prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults - Past Medical History mg (2 tab.) 2 g / day for 3 days in some cases - 5 days in some cases (risk group, participants walking in Maximum Voluntary Ventilation forest and vegetation covered areas, while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - here 1. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g / dl or 4.65 mmol / l). Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, abdominal here increased level of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), Bundle Branch Block accelerated diffuse hair loss, angioedema, tidlywinks urea and creatinine blood d. Method of production of drugs: Table., Film-coated, 300 mg. Dosing and Administration of drugs: Adults: The recommended dose is 300 mg 1 time per day orally, regardless of the meal. hypersensitivity to the drug. 50 mg, 100 mg, 150 mg, 200 mg, tab. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 tidlywinks vysivkopodibnomu leave - 10 days, mouth and skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 to 2 months, nail infection - from 6 to 12 months (depending on tidlywinks tidlywinks growth of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 tidlywinks koktsydioyidomikozi, parakoktsydioyidomikozi tidlywinks histoplasmosis - 3 to 6 months for preventive treatment of adults with immunodeficiency - 400mh/dobu and children tidlywinks 4.8 mg / kg but not more than 400 mg / day. Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of tidlywinks - tidlywinks two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days tidlywinks maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose tidlywinks 10 mg) application period may be extended to one month period, an increased risk over 10 days. Improper use PRVZ here to rapid development of resistance. Preparations of drugs: Table.